- Preview Available
- Scholarly Journal
Intranasal spike and nucleoprotein fusion protein-based vaccine provides cross-protection and reduced transmission against SARS-CoV-2 variants
NPJ Vaccines; London Vol. 10, Iss. 1, (2025): 75.
DOI:10.1038/s41541-025-01123-y
This is a limited preview of the full PDF
Try and log in through your library or institution to see if they have access.